Rhythm Pharmaceuticals (RYTM) has climbed approximately 18% over the past month, pushing above $60 per share as investors have responded to several promising developments in treatments for rare ...

Stay updated on market trends for RYTM. Rhythm Pharmaceuticals Weight Loss Drug Study Shows Significant BMI Reduction For Rare Type Of Obesity Disorder Rhythm's Phase 3 trial shows setmelanotide ...